Related references
Note: Only part of the references are listed.Size control of lipid-based drug carrier by drug loading
Tatsuya Murakami et al.
MOLECULAR BIOSYSTEMS (2010)
Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro
Partha Mukhopadhyay et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Biomimetic Nanocarrier for Direct Cytosolic Drug Delivery
Zhihong Zhang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Targeting nanodisks via a single chain variable antibody - Apolipoprotein chimera
David M. Iovannisci et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
PAMAM-Triamcinolone acetonide conjugate as a nucleus-targeting gene carrier for enhanced transfer activity
Kun Ma et al.
BIOMATERIALS (2009)
The Interleukin-11 Receptor a as a Candidate Ligand-Directed Target in Osteosarcoma: Consistent Data from Cell Lines, Orthotopic Models, and Human Tumor Samples
Valerae O. Lewis et al.
CANCER RESEARCH (2009)
Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides
Bryan R. Meade et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Cholesterol is a determinant of the structures of discoidal high density lipoproteins formed by the solubilization of phospholipid membranes by apolipoprotein A-I
John B. Massey et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2008)
Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes
Tatsuhiro Ishida et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Initial interaction of apoA-I with ABCA1 impacts in vivo metabolic fate of nascent HDL
Anny Mulya et al.
JOURNAL OF LIPID RESEARCH (2008)
Water-dispersed single-wall carbon nanohorns as drug carriers for local cancer chemotherapy
Tarsuya Murakami et al.
NANOMEDICINE (2008)
Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells
Fei Shen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Enhanced cancer-targeted delivery using engineered high-density lipoprotein-based nanocarriers
Ian R. Corbin et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2007)
Synthetic nano-low density lipoprotein as targeted drug delivery vehicle for glioblastoma multiforme
Mina Nikanjam et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Association of a model class a (apolipoprotein) amphipathic α helical peptide with lipid -: High resolution NMR studies of peptide-lipid discoidal complexes
VK Mishra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Development of pH-sensitive liposomes that efficiently retain encapsulated doxorubicin (DXR) in blood
T Ishida et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents
G Zheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Present and future of cell-penetrating peptide mediated delivery systems: Is the Trojan horse too wild to go only to Troy?
E Vives
JOURNAL OF CONTROLLED RELEASE (2005)
Enhanced targeting and killing of tumor cells expressing the CXC chemokine receptor 4 by transducible anticancer peptides
EL Snyder et al.
CANCER RESEARCH (2005)
HDL as a target in the treatment of atherosclerotic cardiovascular disease
P Linsel-Nitschke et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Combinatorial screenings in patients:: The interleukin-11 receptor α as a candidate target in the progression of human prostate cancer
AJ Zurita et al.
CANCER RESEARCH (2004)
OVCAR-3 cells internalize TAT-peptide modified liposomes by endocytosis
MM Fretz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2004)
Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and TAT: A kinetic and efficacy study
YL Tseng et al.
MOLECULAR PHARMACOLOGY (2002)
Loading anticancer drugs into HDL as well as LDL has little affect on properties of complexes and enhances cytotoxicity to human carcinoma cells
A Kader et al.
JOURNAL OF CONTROLLED RELEASE (2002)
Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting
PCN Rensen et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Structural models of human apolipoprotein A-I: a critical analysis and review
CG Brouillette et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2001)
Binding of high density lipoprotein (HDL) and discoidal reconstituted HDL to the HDL receptor scavenger receptor class B type I - Effect of lipid association and APOA-I mutations on receptor binding
KN Liadaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Binding and cross-linking studies show that scavenger receptor BI interacts with multiple sites in apolipoprotein A-I and identify the class A amphipathic α-helix as a recognition motif
DL Williams et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
